Skip to main content

NYSE:CNO - CNO Financial Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $25.20
  • Forecasted Upside: -8.20 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$27.45
▲ +0.22 (0.81%)
1 month | 3 months | 12 months
Get New CNO Financial Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$25.20
▼ -8.20% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for CNO Financial Group in the last 3 months. The average price target is $25.20, with a high forecast of $30.00 and a low forecast of $19.00. The average price target represents a -8.20% upside from the last price of $27.45.

Buy

The current consensus among 4 investment analysts is to buy stock in CNO Financial Group. This rating has held steady since October 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/23/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
5/21/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
8/19/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/17/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/15/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/16/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/16/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/1/2021Morgan StanleyBoost Price TargetEqual Weight$25.00 ➝ $27.00High
i
3/31/2021CitigroupBoost Price Target$23.00 ➝ $25.00Medium
i
3/31/2021Piper SandlerDowngradeOverweight ➝ Neutral$25.00High
i
3/9/2021B. RileyBoost Price TargetBuy$27.00 ➝ $30.00Low
i
3/3/2021Morgan StanleyBoost Price TargetEqual Weight$24.00 ➝ $25.00Low
i
2/25/2021Morgan StanleyBoost Price TargetEqual Weight$24.00 ➝ $25.00High
i
1/15/2021Morgan StanleyBoost Price TargetEqual Weight$20.00 ➝ $24.00Medium
i
1/7/2021B. RileyBoost Price TargetBuy$24.00 ➝ $27.00N/A
i
1/6/2021Piper SandlerBoost Price TargetOverweight$22.00 ➝ $25.00N/A
i
11/18/2020Morgan StanleyBoost Price TargetEqual Weight$19.00 ➝ $20.00Low
i
11/16/2020B. RileyBoost Price TargetBuy$20.00 ➝ $24.00Low
i
Rating by R. Binner at B. Riley
11/4/2020Piper SandlerBoost Price TargetOverweight$20.00 ➝ $22.00High
i
Rating by John Barnidge at Piper Sandler
11/3/2020Morgan StanleyBoost Price TargetEqual Weight$18.00 ➝ $19.00High
i
10/7/2020Piper SandlerBoost Price TargetOverweight$19.00 ➝ $20.00High
i
Rating by John Barnidge at Piper Sandler
10/6/2020Morgan StanleyBoost Price TargetEqual Weight$17.00 ➝ $18.00High
i
9/1/2020Piper SandlerUpgradeNeutral ➝ Overweight$17.00 ➝ $19.00High
i
Rating by John Barnidge at Piper Sandler
8/20/2020Morgan StanleyBoost Price TargetEqual Weight$16.00 ➝ $17.00High
i
8/5/2020Morgan StanleyBoost Price TargetEqual Weight$15.00 ➝ $16.00Medium
i
7/6/2020Morgan StanleyBoost Price TargetEqual Weight$13.00 ➝ $15.00Medium
i
7/2/2020Piper SandlerBoost Price TargetNeutral$14.00 ➝ $15.00Medium
i
Rating by John Barnidge at Piper Sandler
6/18/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$17.00 ➝ $19.00High
i
5/29/2020B. RileyUpgradeNeutral ➝ Buy$15.00 ➝ $20.00High
i
Rating by R. Binner at B. Riley
5/20/2020Piper SandlerInitiated CoverageNeutral$14.00Medium
i
4/21/2020B. RileyLower Price TargetNeutral$18.00 ➝ $15.00High
i
Rating by R. Binner at B. Riley
3/23/2020B. RileyLower Price TargetNeutral$20.00 ➝ $18.00High
i
Rating by R. Binner at B. Riley
3/17/2020Morgan StanleyLower Price TargetEqual Weight$19.00 ➝ $13.00High
i
3/11/2020B. RileyDowngradeBuy ➝ Neutral$24.00 ➝ $20.00High
i
Rating by R. Binner at B. Riley
11/15/2019GuggenheimDowngradeHold$29.00High
i
Rating by Shahriar Pourreza at Guggenheim
9/13/2019CitigroupLower Price TargetNeutral$18.00 ➝ $17.00Low
i
2/14/2019Keefe, Bruyette & WoodsReiterated RatingHold$21.00Low
i
1/9/2019Evercore ISIUpgradeIn-Line ➝ OutperformHigh
i
12/17/2018Keefe, Bruyette & WoodsReiterated RatingHold$22.00Low
i
8/17/2018Keefe, Bruyette & WoodsReiterated RatingHold$24.00Low
i
6/12/2018B. RileyLower Price TargetBuy ➝ Buy$27.00 ➝ $25.00Low
i
5/31/2018Morgan StanleyReiterated RatingEqual WeightMedium
i
5/17/2018Morgan StanleyUpgradeUnderweight ➝ Equal WeightMedium
i
4/25/2018Wells Fargo & CompanySet Price TargetHold$23.00High
i
Rating by Sean Dargan at Wells Fargo & Company
3/12/2018William BlairInitiated CoverageOutperform ➝ OutperformHigh
i
Rating by Adam Klauber at William Blair
2/13/2018Wells Fargo & CompanySet Price TargetHold$25.00Low
i
Rating by Sean Dargan at Wells Fargo & Company
12/21/2017Keefe, Bruyette & WoodsReiterated RatingHold$24.00Low
i
11/6/2017B. RileyReiterated RatingBuyN/A
i
Rating by R. Binner at B. Riley
10/25/2017Wells Fargo & CompanySet Price TargetHold$22.00N/A
i
Rating by Sean Dargan at Wells Fargo & Company
10/18/2017The Goldman Sachs GroupInitiated CoverageNeutral$24.00N/A
i
8/14/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$21.00Low
i
6/20/2017Wells Fargo & CompanyReiterated RatingHoldLow
i
Rating by Sean Dargan at Wells Fargo & Company
6/5/2017Wells Fargo & CompanyReiterated RatingHoldHigh
i
5/31/2017(FBRC)Reiterated RatingOutperform$23.00Low
i
3/17/2017Keefe, Bruyette & WoodsSet Price TargetHold$22.00Medium
i
Rating by Ryan Krueger at Keefe, Bruyette & Woods
2/9/2017BTIG ResearchReiterated RatingHoldN/A
i
Rating by Mark Palmer at BTIG Research
1/26/2017CitigroupInitiated CoverageNeutral$21.00N/A
i
1/23/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$18.00 ➝ $19.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
1/11/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
i
12/13/2016(FBRC)Boost Price TargetOutperform$21.00 ➝ $22.00N/A
i
10/3/2016Keefe, Bruyette & WoodsSet Price TargetHold$19.00 ➝ $17.00N/A
i
9/30/2016Deutsche Bank AktiengesellschaftSet Price TargetHold$18.00 ➝ $16.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
9/30/2016BTIG ResearchDowngradeBuy ➝ NeutralN/A
i
Rating by Mark Palmer at BTIG Research
9/30/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$21.00 ➝ $17.00N/A
i
9/22/2016Wells Fargo & CompanyInitiated CoverageOutperformN/A
i
8/2/2016Keefe, Bruyette & WoodsLower Price TargetMarket Perform$20.00 ➝ $19.00N/A
i
7/28/2016Morgan StanleyReiterated RatingHold$19.00N/A
i
7/28/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$19.00 ➝ $18.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
7/27/2016UBS GroupSet Price TargetHold$18.00N/A
i
7/15/2016BTIG ResearchReiterated RatingBuyN/A
i
Rating by Mark Palmer at BTIG Research
7/12/2016UBS GroupReiterated RatingHoldN/A
i
7/7/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$20.00 ➝ $19.00N/A
i
Rating by Yaron Kinar at Deutsche Bank Aktiengesellschaft
7/7/2016CitigroupLower Price TargetBuy$21.00 ➝ $20.00N/A
i
7/6/2016Evercore ISIInitiated CoverageHold$19.00N/A
i
(Data available from 5/16/2016 forward)
CNO Financial Group logo
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
Read More

Today's Range

Now: $27.45
$27.10
$27.48

50 Day Range

MA: $25.58
$24.29
$27.23

52 Week Range

Now: $27.45
$12.05
$27.85

Volume

1,285,653 shs

Average Volume

927,266 shs

Market Capitalization

$3.61 billion

P/E Ratio

8.66

Dividend Yield

1.76%

Beta

1.41

Frequently Asked Questions

What sell-side analysts currently cover shares of CNO Financial Group?

The following Wall Street research analysts have issued stock ratings on CNO Financial Group in the last year: B. Riley, Citigroup Inc., Morgan Stanley, Piper Sandler, The Goldman Sachs Group, Inc., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CNO.

What is the current price target for CNO Financial Group?

5 Wall Street analysts have set twelve-month price targets for CNO Financial Group in the last year. Their average twelve-month price target is $25.20, suggesting a possible downside of 8.2%. B. Riley has the highest price target set, predicting CNO will reach $30.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $19.00 for CNO Financial Group in the next year.
View the latest price targets for CNO.

What is the current consensus analyst rating for CNO Financial Group?

CNO Financial Group currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CNO will outperform the market and that investors should add to their positions of CNO Financial Group.
View the latest ratings for CNO.

What other companies compete with CNO Financial Group?

How do I contact CNO Financial Group's investor relations team?

CNO Financial Group's physical mailing address is 11825 NORTH PENNSYLVANIA STREET, CARMEL IN, 46032. The financial services provider's listed phone number is (317) 817-6100 and its investor relations email address is [email protected] The official website for CNO Financial Group is www.cnoinc.com.